# Corteva, Inc. Common Stock (CTVA) — Stock CV

Corteva, Inc. is a $8.83B materials company. Revenue grew 3.7% over the last year, it keeps 6¢ of every dollar of sales as profit, and it holds more cash than debt. It trades at 8.8× earnings — near the lowest of its own history.

> Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products.

## Identity

- **Ticker**: CTVA
- **Sector**: Basic Materials
- **Industry**: SIC: 0100
- **Headquarters**: INDIANAPOLIS, IN
- **Employees**: 21 500
- **Website**: https://www.corteva.com
- **Market cap**: $8.83B
- **Last price**: $13.23
- **Financial profile**: Mixed

## Vitals (TTM)

- **Revenue**: $17.8B
- **Net income**: $1.01B
- **Free cash flow**: $629M
- **Net cash**: $1.95B
- **P/E**: 8.8
- **Revenue growth (YoY)**: 3.7%

## Skills (profile scores, 0–100)

| Pillar | Score |
|---|---|
| Valuation | 95 |
| Growth | 26 |
| Profitability | 43 |
| Health | 61 |
| Quality | 85 |
| Moat | 31 |

## Qualifications (beginner checklist) — 10 of 11 passed

- [x] Revenue growing — +3.7% YoY
- [x] Profitable — $1.01B TTM
- [x] Profit growing — +0.5% YoY
- [x] Generates cash — $629M TTM
- [x] Debt under control — more cash than debt
- [x] Established company — $8.83B market cap
- [x] Not printing shares — -8.6% shares over ~5y
- [x] Proven track record — 6/7 profitable years
- [ ] Financially stable — health score 36/100
- [x] Pays a dividend — yield 5.48%
- [x] Valuation not extreme — P/E 8.8

## Experience (career milestones)

- **2025** — The company introduced Forcivo, a fungicide for corn and soybeans containing flutriafol, azoxystrobin
- **FY2024** — Became debt-free: cash now exceeds total debt
- **2024** — Also in November 2024, the company acquired the naming rights to the Indiana Farmers Coliseum at the Indiana State…
- **2023** — I. du Pont de Nemours and Company, the former corporate entity of DuPont which was designated as the predecessor to…
- **2023** — The company acquired Stoller Group, a maker of natural pesticides for $1.2 billion
- **FY2021** — Best year on record: $1.76B net income
- **FY2020** — Turned profitable: $681M net income after a loss year
- **FY2020** — Positive free cash flow every year since: 6-year streak
- **FY2019** — Revenue already above $10B: $13.8B in first reported year
- **2019** — DowDuPont completed the corporate spin-off of the company and Corteva became a public company
- **2017** — Corteva was formed in…

## Strengths

- High gross margin (49.5%)
- Net cash position after subtracting debt from cash
- Interest covered 9.0× by operating earnings
- Piotroski F-Score 8/9 — fundamentally strong checklist

## Watch-outs

- Loss-making in 1 of the recent years

## Track record

| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2021 | $15.7B | $1.76B | $2.12B |
| FY2022 | $17.5B | $1.15B | $267M |
| FY2023 | $17.2B | $735M | $1.17B |
| FY2024 | $16.9B | $907M | $1.55B |
| FY2025 | $17.4B | $1.09B | $2.81B |

---

Source: https://stockcv.com/CTVA — derived from company filings; may be delayed or incomplete. Information, not investment advice.